When we bring home a cluster of oyster mushrooms from the shop, all we see are the fruiting bodies. Most of the activity that makes this fungus an interesting research organism takes place in the mycelium. This is what grows through wood or straw, releases enzymes into its surroundings and, for some tiny animals, delivers a very unpleasant surprise.
There is a lot written about oyster mushrooms online. To avoid getting lost in it all, we will consistently distinguish three things: what the fungus does in nature, what it achieved in a particular technical experiment and what has actually been demonstrated in humans. One does not automatically imply the other.
What it looks like and when to find it
The oyster mushroom, Pleurotus ostreatus, usually forms fan-shaped to tongue-shaped caps about 4–20 cm wide. They often grow in clusters, overlapping like roof tiles. Their colour tends to be grey to bluish grey, but it varies. The whitish to greyish gills run a long way down the short, lateral stem; sometimes the stem is barely discernible. The flesh is springy and considerably tougher in the stem. The spore print is whitish to pale greyish violet.
The Czech Mycological Society gives the main growing season as October to December, extending into spring during mild winters. So this is one of the mushrooms that mean we need not put our baskets away for good at the end of autumn. Its atlas rates it as an excellent edible mushroom.
(Source: Czech Mycological Society – oyster mushroom)
Where it lives and what it actually eats
We find it mainly on the trunks and stumps of broadleaved trees: beech, willow, poplar or walnut, for example. It can grow on dead wood as well as living trees; it rarely colonises conifers. It is not confined to deep woodland, also appearing in parks, avenues of trees and waterside vegetation. BOTANY.cz records it from the temperate zone and gives a broader season of September to May. This is no calendar contradiction: actual growth depends on local conditions.
(Source: BOTANY.cz – Pleurotus ostreatus)
The oyster mushroom is one of the fungi that cause white rot. It can attack lignin, a resistant component of plant cell walls. In research on strain PC9, scientists compared the proteins secreted during growth on poplar wood, wheat straw and a glucose medium. On the plant substrates, the fungus produced substantial amounts of laccases and certain peroxidases, among other enzymes. Analysis of the substrates also demonstrated preferential loss of lignin relative to carbohydrate components.
So this is not a matter of a single universal enzyme. The fungus has a whole toolkit, and how it uses it changes with its environment. Its ability to chemically attack plant structures that are difficult to break down helps explain the interest in using it against certain pollutants.
(Source: Fernández-Fueyo et al., 2016 – oyster mushroom enzymes during the breakdown of wood and straw)
Not every “oyster mushroom” is Pleurotus ostreatus
In English texts, the name oyster mushrooms refers to several species. Cornell University's cultivation guide distinguishes, for example, the more cold-loving Pleurotus ostreatus from Pleurotus pulmonarius for the warmer season. The same general commercial name is therefore no guarantee of the same fungus or the same properties. In this article, we stick to the species Pleurotus ostreatus; we do not simply transfer findings for other oyster mushrooms to it.
(Source: Cornell University – stages of cultivation and strain selection)
Mycelium that hunts animals
Here we come to one of its most delightful real curiosities. The oyster mushroom is not dependent solely on plant material. Its mycelium can rapidly paralyse and kill nematodes, tiny wormlike animals.
A 2023 study in Science Advances described fragile structures on the hyphae known as toxocysts. Scientists detected the volatile substance 3-octanone inside them. In experiments with the nematode Caenorhabditis elegans, it disrupted cell membranes, triggered abrupt changes in calcium movement into cells and led to cell death. Mutant oyster mushrooms that did not form toxocysts also lost the corresponding ability to paralyse nematodes.
Experiments with the isolated substance required high concentrations; this is not a description of the normal composition of the air around a cluster of mushrooms. And the authors present the possible explanations that hunting supplies nitrogen in a nutrient-poor environment or protects the mycelium from animals as ecological hypotheses. The attack itself, observed in the laboratory, is documented; that does not settle all its functions in nature.
(Source: Lee et al., 2023 – how oyster mushrooms paralyse nematodes)
Our understanding continues to develop. A 2026 paper compared twenty strains from six species of the genus Pleurotus. It found differences in the production of toxic droplets and results supporting the possibility that a mixture of substances contributes to the effect, rather than 3-octanone alone. Other proposed components were still only candidates. It is therefore inaccurate to present a single molecule as the definitive explanation of the entire phenomenon in all oyster mushrooms.
(Source: Lloyd et al., 2026 – chemical composition of droplets in oyster mushrooms)
Does it really break down toxic chemicals?
Yes, we have such results for specific substances under specific conditions. The use of fungi to remove pollution is collectively known as mycoremediation. But instead of making the grand promise that oyster mushrooms will “eat all poisons”, let us look at the individual experiments.
DDT: a substantial decrease does not mean complete breakdown
In 2010, Purnomo and co-authors studied spent oyster mushroom growing substrate. In artificially contaminated soil, they reported a decrease in DDT after 28 days of 40 % in the sterilised treatment and 80 % in the non-sterilised treatment. Using radioactively labelled DDT, they also monitored mineralisation, meaning the conversion of the labelled carbon all the way to carbon dioxide. After 56 days, this reached 5,1 % and 8,0 %, respectively.
Those figures describe two different things and cannot be used interchangeably. An eighty per cent decrease in the original DDT did not mean that eighty per cent of everything had been converted into harmless end products. Moreover, the experiment involved spent substrate and its entire biological system, rather than proving the effect of the pure fungus alone in every environment. The difference between sterilised and non-sterilised soil is another reason not to overlook the surrounding microorganisms.
(Source: Purnomo et al., 2010 – spent oyster mushroom substrate and DDT)
Endocrine-disrupting substances: Czech research too
Křesinová and co-authors tested strain HK 35 against selected hormonally active substances, including bisphenol A, certain oestrogens, triclosan and nonylphenol. Under model laboratory conditions, they reported degradation efficiency of over 90 % within twelve days. In reactors, they also worked with spent oyster mushroom substrate and real municipal wastewater.
Interestingly, they monitored not only the analytically measured decrease in the substances, but also the suppression of the sample's oestrogenic activity. This is essential when assessing the result. In the final pilot trickle-bed reactor at a wastewater treatment plant, they achieved removal of more than 76 % of the monitored substances present during ten days of operation.
The paper appeared in a journal in 2018, having been published electronically in 2017. It represents a real step beyond the laboratory flask, but remains a pilot validation of a particular technology. It is no general guarantee for every treatment plant or every kind of pollution.
(Source: Křesinová et al., 2018 – an oyster mushroom bioreactor and hormonally active substances)
PCBs: manageable parts of the problem and clear limits
Another Czech study used spent oyster mushroom substrate to clean water containing polychlorinated biphenyls. Laboratory optimisation was followed by a pilot reactor with a working volume of 500 litres, used to treat 4000 litres of real contaminated groundwater.
The results differed significantly depending on the particular PCBs: the reactor removed 82 % of dichlorinated, 80 % of trichlorinated, 65 % of tetrachlorinated and 30–50 % of pentachlorinated congeners. They observed no degradation of hexa- and heptachlorinated congeners. They also detected transformation products, chlorobenzoic acids, confirming that biological degradation was involved.
This is a very clear example of why it pays to read beyond the headline “fungus breaks down PCBs”. The technology handled some components of the mixture considerably better than others. And a transformation product is not automatically a harmless substance.
(Source: Šrédlová et al., 2020 – PCBs in contaminated groundwater)
Polycyclic aromatic hydrocarbons
In 2000, Baldrian and co-authors demonstrated the action of oyster mushrooms on several polycyclic aromatic hydrocarbons in non-sterile soil, including benzo[a]pyrene. The experiment lasted fifteen weeks and also included treatments with cadmium and mercury. The original soil microflora also played a role. Higher metal contamination could limit the fungus's growth and contribution.
Here too, we see a working biological tool with conditions attached to its use, rather than an indestructible universal cleaner. Its effectiveness depends on the composition of the pollution and the organism's ability to thrive in that environment at all.
(Source: Baldrian et al., 2000 – degradation of aromatic hydrocarbons in soil)
What these experiments do not imply
When reading studies like these, we need to distinguish between a substance being trapped on the substrate, its chemical transformation, complete mineralisation and an actual reduction in toxicity. These are different outcomes, not different names for the same success. Nor do the experiments listed justify claiming that oyster mushrooms will remove any poison in any environment.
And they certainly do not imply that eating oyster mushrooms will clean the human body in the same way. A bioreactor with mycelium, substrate and controlled operating conditions is not a digestive system. Linking environmental degradation to a human “detox” would be an unsupported leap.
Oyster mushrooms cannot break down metals
With metallic elements, the situation differs from that with organic molecules. Biological degradation cannot turn cadmium into carbon and water. The fungus can take up and accumulate metals; from a food perspective, that can be a problem.
A study of 59 cultivated oyster mushroom strains demonstrated differences in the accumulation of the monitored elements, their distribution between cap and stem, and the influence of the substrate. In practical terms, knowing that oyster mushrooms grew on some waste material is therefore not enough. We also need to know what it contained and what passed into the fruiting bodies. Growing food and technically cleaning contaminated material are not interchangeable processes; the species being edible does not in itself guarantee the safety of a crop obtained this way.
(Source: Golian et al., 2022 – accumulation of elements in the fruiting bodies of 59 oyster mushroom strains)
How it is grown
Instead of a woodland log, we can offer oyster mushrooms a prepared lignocellulosic substrate. The grower first selects a strain, prepares the substrate and inoculates it with spawn, meaning cultivated mycelium. Once the substrate is colonised, the fruiting stage follows, during which environmental conditions change. Cornell's guide emphasises temperature, humidity, light and fresh air supply. Light is not an energy source for photosynthesis here, but it influences the proper development of fruiting bodies.
A single temperature figure for all oyster mushrooms would be misleading. It depends on the species, strain and stage of cultivation. For a beginner, it makes sense to use spawn of known origin or a ready-colonised block and instructions specific to it, rather than a random universal guide from the internet.
(Source: Cornell University – strain selection, substrate preparation and fruiting bodies)
A curiosity for biology enthusiasts: reproduction is not just about “male and female”. Oyster mushrooms have a sexual compatibility system controlled by two regions of the genome, matA and matB. Successful fusion of compatible mycelia produces a phase with two nuclei per cell. Research published in PLOS Genetics in 2026 showed through specific crosses that compatibility at both regions matters. It is a clear example of how differently fungal reproduction can be organised from what we know in animals.
(Source: Lee et al., 2026 – genetics of sexual compatibility in oyster mushrooms)
A mushroom that creates its own air currents
Spores do not simply have to wait for wind to happen to wander between the caps. Research published in PNAS in 2016 included oyster mushrooms, shiitake and a species of Agaricus. It showed that water evaporation cools the surroundings of the fruiting body, and the resulting airflow helps spores escape even from narrow spaces beneath the cap.
In oyster mushrooms specifically, they measured air in the gaps between and beneath the caps that was 1–2 °C cooler than the surroundings. In experiments, they also monitored dispersal in boxes protected from external airflow. So this is more than a theoretical calculation. The fungus uses the quite ordinary physics of evaporation and differences in air density for something that looks surprisingly ingenious.
This is no claim that the mushroom consciously switches on a fan or controls the weather. It is a small, local air current, but for a microscopic spore it provides significant help with transport.
(Source: Dressaire et al., 2016 – airflow and spore dispersal)
Mycelium as a material binder
What if, instead of fruiting bodies, we grew a lightweight material? That too is being studied with oyster mushrooms. Branching hyphae grow through plant particles and bind them into a composite. The result is therefore not a piece of fungus alone, but a material made up of mycelium and remnants of the original substrate.
In 2022, Vašatko and co-authors studied composites made with oyster mushrooms and, separately, with reishi. They worked mainly with beech sawdust and tested properties including density, behaviour under compression and bending, and water absorption. For the oyster mushroom samples, they described growth in prepared moulds followed by drying. So a living fungus first helped create the shape, but the tested product had already been dried.
The authors relate their findings to applications such as temporary structures and insulation. But we cannot turn these experiments into a promise that an ordinary growing block will let us build a safe house straight away. Mechanical properties, behaviour in damp conditions and the particular processing method need to be verified for the intended use.
(Source: Vašatko et al., 2022 – material properties of mycelium composites)
Living oyster mushroom in 3D printing ink
A 2024 paper went a step further: researchers prepared a hydrogel for 3D printing containing living Pleurotus ostreatus mycelium. They used malt extract as a nutrient, carboxymethylcellulose and maize starch as thickeners, and agar as a gelling component. Printing was not the end of the process; the mycelium continued to grow. The authors monitored how the height, weight and hardness of the printed objects changed as this happened.
Successful printing without a sterile printing environment was also interesting. But that applies to their particular procedure; it does not mean contamination has ceased to be a problem or that any homemade mixture can be printed in the same way. The paper presents an experimental method of producing living materials, rather than a finished universal food printer or proof that every similar printed object is safe for health.
(Source: Lin et al., 2024 – 3D printing of hydrogel with living oyster mushroom mycelium)
Oyster mushrooms and vitamin D: a curiosity without a guaranteed dose
Oyster mushrooms contain ergosterol, which is converted into vitamin D2 by UVB radiation. Research using both sunlight and controlled UVB exposure demonstrated an increase in its content; factors included the duration and intensity of exposure and the size of the pieces.
This is a well-documented food-processing possibility, rather than a guarantee that every oyster mushroom bought in a shop has the same high vitamin D content. Without knowing how it was grown and subsequently processed, we cannot use this ability to infer a specific dose in our serving. Nor can we simply transfer experimental sunlight exposure conditions in the subtropics to a Czech windowsill in November without taking measurements.
(Source: Keflie et al. – UVB and vitamin D2 content in oyster mushrooms)
Health effects: what the studies actually say
Oyster mushrooms as food, powdered fruiting bodies, an isolated polysaccharide and a laboratory extract are not identical research interventions. These differences are not quibbles over words. If a particular preparation works in one experiment, that does not automatically give the entire species the same effect in every form.
Cholesterol and blood sugar: earlier hopes and a more recent sober result
A 2020 systematic review included eight clinical studies of oyster mushroom consumption. Some produced favourable results for blood glucose, blood lipids or blood pressure. However, the authors also described the evidence as weak: problems with control groups, randomisation, blinding or descriptions of methods were common. It is therefore not honest to turn the review into the simple claim that “oyster mushrooms are proven to treat diabetes and high cholesterol”.
(Source: Dicks and Ellinger, 2020 – systematic review of clinical studies)
An important, more recent counterweight came from a double-blind randomised study in 2026. In 46 analysed adults with mildly elevated LDL cholesterol, it compared four weeks of daily consumption of 8,4 g of oyster mushroom powder containing 3 g of beta-glucans with a control drink without oyster mushroom. It did not demonstrate a reduction in LDL cholesterol compared with the control. Additional analyses of certain markers of cholesterol absorption are interesting for further research, but they do not replace this main finding.
A negative result does not disprove every possible effect of every oyster mushroom preparation. It does, however, refute the impression that a beneficial effect on LDL has been established beyond doubt. The dose given describes the experiment; it is not a recommendation for use.
(Source: Johnen et al., 2026 – randomised study of oyster mushroom powder and LDL cholesterol)
Pleuran and respiratory infections: a real clinical finding with limited applicability
Pleuran is a beta-glucan isolated from oyster mushrooms. In a study published in 2025, children with recurrent respiratory tract infections received either a specific pleuran preparation with vitamin D and zinc or a control preparation with vitamin D and zinc without pleuran for three months. Of 249 enrolled children, 217 were analysed. The average number of infections was 2,35 versus 2,77, approximately 15 % lower in the pleuran group.
This is a clinical finding, rather than just a cell experiment. At the same time, it concerns a specific preparation, a selected group of children and a short follow-up period. The research was funded by PLEURAN, s.r.o.; 32 enrolled children were not included in the final analysis. These circumstances need to be stated when assessing the reliability and generalisability of the result.
The paper does not allow us to conclude that an ordinary oyster mushroom meal will prevent infections, that every supplement works in the same way or that it replaces treatment. The general advertising promise “boosts immunity” would be much broader than the result actually measured.
(Source: Jesenak et al., 2025 – controlled study of a specific pleuran preparation)
Antitumour activity: a cell culture is not a patient
A 2008 paper described how an oyster mushroom extract inhibited the proliferation of selected human breast and colon cancer cell lines. Among other things, the authors monitored changes in the cell cycle. The word “human” here refers to the origin of the cells, rather than a clinical study in humans. These were laboratory cultures exposed to an extract.
Such a finding can prompt further research. It does not prove that eating oyster mushrooms treats cancer, prevents it or extends patients' lives. Without this essential clarification, we will therefore not use the sentence “oyster mushrooms have proven anticancer effects”.
(Source: Jedinak and Sliva, 2008 – effects of an extract on cancer cell lines)
“Natural statin” is not a good shorthand either
We often read that oyster mushrooms contain lovastatin and can therefore replace cholesterol-lowering medicines. Yet back in 2016, the joint expert commission of the German institutions BVL and BfArM warned that some published high lovastatin levels in edible mushrooms did not stand up to scrutiny because of fundamental methodological shortcomings. Their own verification showed considerably lower quantities or values below the limit of quantification.
This does not mean that a single document has disproved every possible instance of lovastatin biosynthesis in every strain and cultivation method. It means that ordinary oyster mushrooms cannot honestly be offered as a standardised, clinically equivalent substitute for a medicinal statin. Analysis of a particular substance, its availability in the body and its effect on the patient are separate questions.
(Source: BVL/BfArM, 2016 – critical assessment of data on lovastatin in edible mushrooms, pages 11–14)
MykoRIK's position: evidence instead of selling hope
At MykoRIK, we oppose medical misinformation, unsupported promises and the exploitation of sick people's trust. A product's price, the label “natural” or a reference to traditional Chinese medicine is no proof of its effectiveness. When someone turns a laboratory result into a promise of curing a person, they skip the very thing that matters: verifying whether the approach actually helps patients and what risks it carries.
We consider it unacceptable to sell hope to sick people through unsupported promises of treatment. Encouraging people to postpone or abandon effective treatment is particularly dangerous. Through NCCIH, the US NIH explicitly warns that unproven products should not replace or delay cancer treatment and that delaying it can reduce the chances of success.
(Source: NIH/NCCIH – unproven approaches and the risk of delaying cancer treatment)
But we will demand the same precision from our own criticism. “An effect has not been demonstrated” is not the same as “ineffectiveness has been demonstrated”. We will honestly report positive findings, negative results and what we do not yet know. That is how we can be firm towards charlatan practices while remaining fair to research.
Oyster mushrooms in the kitchen
On the plate, we can let them shine in quite ordinary ways: fry them in a pan, add them to soup or cook them into a mushroom mixture to serve with an accompaniment. We can choose a recipe to suit our tastes; we need not turn it into a course of treatment. From the description of the mushroom above, we already know to expect tough stems.
What we can take away from this
The oyster mushroom is an interesting edible fungus, a useful decomposer of plant matter and a valuable research organism. We have specific evidence of nematode hunting, its enzyme toolkit and its use in removing selected pollutants. In some applications, research has progressed as far as pilot reactors.
Health research needs to be described with the same precision. Some results are promising, others negative, and many common claims go beyond what the studies actually demonstrated. We do not need to praise oyster mushrooms as a cure-all for them to deserve attention. And none of the results described here is a reason to use them to replace prescribed treatment.